# Starling Oncology, Inc.: Form SCHEDULE 13D/A, filed Apr 23, 2025

- Company: [Starling Oncology, Inc.](/companies/stln.md) (CIK 1799191)
- Form: SCHEDULE 13D/A
- Filed: 2025-04-23
- Accepted by EDGAR: Apr 23, 2025, 18:20 ET
- Period: not reported
- Accession: 0001104659-25-038121
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1799191/000110465925038121/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1799191/000110465925038121/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1799191/000110465925038121/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Apr 23, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-038121. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.